Health4 days ago
EyePoint Pharmaceuticals Secures $150M in Public Offering
EyePoint Pharmaceuticals has successfully priced its underwritten public offering at $12.00 per share, aiming to raise approximately $150 million in gross proceeds. This significant capital infusion...
